10,168 Results

Even younger nightshift workers shown to need to pee more, worsening quality of lifeĀ 

 Added 1 day ago

Millions of people work nights, but increasingly scientists are finding that night work is associated with health problems.

Alcon acquires Power Vision Inc., provider of fluid based intraocular lens implants

 Added 1 day ago

Alcon, announced that it has acquired PowerVision, Inc., a privately-held, US-based medical device development company focused on creating fluid-based intraocular...

Analysis of phase III DECLARE-TIMI 58 trial showed that Farxiga reduced the risk of adverse CV events

 Added 1 day ago

Positive results from a pre-specified sub-analysis of the Phase III DECLARE-TIMI 58 trial showed that Farxiga (dapagliflozin) from AstraZeneca, reduced...

FDA approves sNDA for Avycaz to include pediatric patients 3 months and older

 Added 1 day ago

Allergan plc announced that the FDA has approved the company's supplemental New Drug Application (sNDA) for Avycaz (ceftazidime and avibactam),...

REDUCE-IT study shows Vascepa can provide a 30% risk reduction in total CV events

 Added 1 day ago

Amarin Corporation plc presented new data from its landmark cardiovascular outcomes study of its prescription therapy, Vascepa (icosapent ethyl), the...

Acute & Advanced Heart Failure - updates and expert opinions

 Added 1 day ago

Updates to treatment timing window from the REALITY-AHF study, latest expert opion blogs from Professor Gerhard Polzl and a new prognosis scoring system from the ACUTE study.

MOMENTUM 3 study of HeartMate 3 LVAD meets primary endpoint in heart failure

 Added 2 days ago

Abbott announced new late-breaking data from the MOMENTUM 3 study, the world's largest randomized controlled trial to assess outcomes in...

Data from RADIANCE-HTN SOLO trial of Paradise Renal Denervation System for hypertension results

 Added 2 days ago

ReCor Medical announced the 6 month "on-medication" results from its RADIANCE-HTN SOLO clinical trial with simultaneous publication in Circulation, and...

Phase IV AUGUSTUS trial of Eliquis shows superiority in non-valvular atrial fibrillation

 Added 2 days ago

Bristol-Myers Squibb/Pfizer announced results from the Phase IV AUGUSTUS trial evaluating Eliquis (apixaban) versus vitamin K antagonists (VKAs) in patients...

FDA approves Trazimera biosimilar to Herceptin to treat breast and gastric cancers

 Added 2 days ago

The FDA has approved Trazimera (trastuzumab-qyyp), a biosimilar to Herceptin (trastuzumab), for the treatment of human epidermal growth factor receptor-2...

Load more